BioSpace News Archive

bluebird bio, Inc. (Nasdaq: BLUE) today announced that new data from its early- and late-stage investigational gene and cell therapy programs will be presented during the 60th Annual Meeting of the American Society of Hematology (ASH) in San Diego, California, December 1 – 4.

DJO, a leading provider of medical technologies designed to get and keep people moving, introduced the EMPOWR Porous™ Knee System and EMPOWR™ Complex Primary Knee System at the 2018 Annual Meeting of the American Association of Hip and Knee Surgeons (AAHKS) today (Booth # 510).

Data Reinforce Breadth of Cell Therapy Portfolio and Commitment to Continued Innovation for People with Advanced Cancers

PeraHealth, a provider of predictive, real-time clinical surveillance solutions, announced the appointment of Greg White as its chief executive officer.

Verastem, Inc. (Nasdaq:VSTM) (Verastem Oncology or the Company), focused on developing and commercializing medicines to improve the survival and quality of life of cancer patients, today announced that eight abstracts have been selected for presentation, including one oral presentation, at the upcoming American Society of Hematology

New agreement between National Comprehensive Cancer Network and Syapse will augment health information technology around cancer care

The scholars and clinicians will discuss their proposals in a Webinar Nov. 15 at 12 Noon EST

The collaboration brings together deep clinical expertise with NuMedii’s Artificial Intelligence Drug Discovery technology, which will enable the discovery of novel targets and precision drug candidates for both acute and chronic forms of the disease.

Next FutureLink to be held June 11-13, 2019 in Barcelona.

To Help Raise Awareness of Lung Cancer in Women, the Lung Cancer Research Foundation is Encouraging the Public to “Blow a Kiss” to Someone They Love on Social Media